Rockwell Medical (RMTI) Operating Leases (2019 - 2026)

Rockwell Medical's Operating Leases history runs 8 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• Quarterly Operating Leases rose 66.27% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 66.27% YoY) and the FY2025 annual result came in at $1.5 million, down 14.42% from the prior year.
• Operating Leases was $4.8 million for Q1 2026 at Rockwell Medical, up from $1.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $7.4 million in Q1 2022 and bottomed at $1.4 million in Q4 2023.
• A 5-year average of $3.0 million and a median of $2.2 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases tumbled 70.08% — and 2024, when it soared 117.9%.
• Rockwell Medical's Operating Leases stood at $2.6 million in 2022, then slumped by 44.48% to $1.4 million in 2023, then gained by 18.56% to $1.7 million in 2024, then declined by 14.42% to $1.5 million in 2025, then jumped by 226.82% to $4.8 million in 2026.
• Business Quant data shows RMTI's Operating Leases at $4.8 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.